Search all trials

Find therapies in clinical trials near you – page 71

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Hodgkin's disease

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab and Chemotherapy for Patients with Newly Diagnosed Classical Hodgkin Lymphoma

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Bleomycin

Contact Research Centre

Neoplasm malignant+2

Not recruiting

Registered drugNo placebo

Study on the Safety and Effects of LY2880070 and Gemcitabine in Patients with Advanced or Metastatic Cancer, Focusing on Ovarian Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Gemcitabine

Contact Research Centre

Diffuse large B-cell lymphoma+1

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Glofitamab with Drug Combination for Untreated Large B-Cell Lymphoma Patients

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Alopecia areata

Not recruiting

Registered drug

Study on Baricitinib for Treating Children Aged 6 to 17 with Alopecia Areata

Registered drug

Poland

Participants:0–17 years
Substances:Baricitinib

Contact Research Centre

Type 2 diabetes mellitus

Not recruiting

InvestigationalNo placebo

Study on How Insulin Icodec and Semaglutide Help Control Blood Sugar in Patients with Type 2 Diabetes

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Insulin Icodec

Contact Research Centre

Small cell lung cancer recurrent

Not recruiting

Registered drugNo placebo

Study of Tarlatamab Treatment for Patients with Small Cell Lung Cancer Who Have Not Responded to Two or More Previous Treatments

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Siltuximab

Contact Research Centre

Diabetes mellitus

Not recruiting

InvestigationalNo placebo

A Study of Long-Term Safety of Teplizumab in Children and Adolescents with Recently Diagnosed Type 1 Diabetes

InvestigationalNo placebo

Poland

Participants:0–17 years · 18–64 years
Substances:Teplizumab

Contact Research Centre

Parkinson's disease

Not recruiting

Investigational

Study of Suvecaltamide for Treating Moderate to Severe Tremor in Parkinson's Disease Patients

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Suvecaltamide

Contact Research Centre

Neurodermatitis

Not recruiting

Investigational

Study of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Rocatinlimab

Contact Research Centre

Renal cancer metastatic

Not recruiting

Registered drug

Study on Cabozantinib, Nivolumab, and Ipilimumab for Patients with Advanced or Metastatic Kidney Cancer Who Have Not Received Prior Treatment

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Cabozantinib

Contact Research Centre

Renal cell carcinoma

Not recruiting

Registered drugNo placebo

Study Comparing Tivozanib and Nivolumab Combination to Tivozanib Alone in Patients with Renal Cell Carcinoma After Previous Immune Therapy

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Cystic fibrosis

Not recruiting

Registered drugNo placebo

Long-term safety and efficacy study of elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis who have non-F508del genetic mutations

Registered drugNo placebo

Poland

Participants:0–17 years · 18–64 years
Substances:Elexacaftor

Contact Research Centre

Find therapies in clinical trials near you – page 71

864 trials match your criteria

Hodgkin's disease

Study of Pembrolizumab and Chemotherapy for Patients with Newly Diagnosed Classical Hodgkin Lymphoma

Neoplasm malignant+2

Study on the Safety and Effects of LY2880070 and Gemcitabine in Patients with Advanced or Metastatic Cancer, Focusing on Ovarian Cancer

Diffuse large B-cell lymphoma+1

Study on the Effectiveness and Safety of Glofitamab with Drug Combination for Untreated Large B-Cell Lymphoma Patients

Alopecia areata

Study on Baricitinib for Treating Children Aged 6 to 17 with Alopecia Areata

Type 2 diabetes mellitus

Study on How Insulin Icodec and Semaglutide Help Control Blood Sugar in Patients with Type 2 Diabetes

Small cell lung cancer recurrent

Study of Tarlatamab Treatment for Patients with Small Cell Lung Cancer Who Have Not Responded to Two or More Previous Treatments

Diabetes mellitus

A Study of Long-Term Safety of Teplizumab in Children and Adolescents with Recently Diagnosed Type 1 Diabetes

Parkinson's disease

Study of Suvecaltamide for Treating Moderate to Severe Tremor in Parkinson's Disease Patients

Neurodermatitis

Study of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments

Renal cancer metastatic

Study on Cabozantinib, Nivolumab, and Ipilimumab for Patients with Advanced or Metastatic Kidney Cancer Who Have Not Received Prior Treatment

Renal cell carcinoma

Study Comparing Tivozanib and Nivolumab Combination to Tivozanib Alone in Patients with Renal Cell Carcinoma After Previous Immune Therapy

Cystic fibrosis

Long-term safety and efficacy study of elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis who have non-F508del genetic mutations

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.